Microbot Medical Inc. (MBOT) shareholders
Close on Nov 17, 2026Market cap $46.28MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Intracoastal Capital LLC Joint filing with Mitchell P. Kopin (8.20%), Daniel B. Asher (8.20%) | 6,002,185 | 8.20% | 13G (passive) | Jan 15, 2026 |
| Mitchell P. Kopin Joint filing with Daniel B. Asher (9.99%), Intracoastal Capital LLC (9.99%) | 4,200,951 | 9.99% | 13G (passive) amendment | Jun 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MBOT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 2,906,810 | 4.33% | $5.67M | −2,715 | 0.00% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 1,268,453 | 1.89% | $2.47M | New | 0.00% |
| BlackRock, Inc. | 902,411 | 1.34% | $1.76M | +45,013 | 0.00% |
| Geode Capital Management, LLC | 836,271 | 1.25% | $1.63M | +75,440 | 0.00% |
| UBS Group AG | 806,847 | 1.20% | $1.57M | −10,098 | 0.00% |
| DnB Asset Management AS | 677,498 | 1.01% | $1.32M | – | 0.00% |
| Stifel Financial Corp | 589,924 | 0.88% | $1.15M | +16,849 | 0.00% |
| Marshall Wace, Llp | 541,963 | 0.81% | $1.06M | +60,918 | 0.00% |
| Susquehanna International Group, Llp | 525,827 | 0.78% | $1.03M | −398,480 | 0.00% |
| Vanguard Fiduciary Trust Co | 431,033 | 0.64% | $840.51K | +30,808 | 0.00% |
| State Street Corp | 303,569 | 0.45% | $591.96K | – | 0.00% |
| AlphaCentric Advisors LLC | 250,000 | 0.37% | $487.50K | +50,000 | 0.41% |
| Northern Trust Corp | 147,530 | 0.22% | $287.68K | +4,170 | 0.00% |
| Group One Trading, L.P. | 106,429 | 0.16% | $207.54K | +59,866 | 0.00% |
| Jane Street Group, LLC | 106,134 | 0.16% | $206.96K | −35,407 | 0.00% |
| American Century Companies Inc | 93,314 | 0.14% | $181.96K | +80,896 | 0.00% |
| Millennium Management LLC | 86,302 | 0.13% | $168.29K | −368,444 | 0.00% |
| Invesco Ltd. | 52,201 | 0.08% | $101.79K | +22,781 | 0.00% |
| Charles Schwab Investment Management Inc | 50,000 | 0.07% | $97.50K | – | 0.00% |
| Vontobel Holding Ltd. | 48,088 | 0.07% | $93.77K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 71 | 11M | 16.9% | 11 / 24 | 13 / 17 | 2M | 5M |
| Q1 2026 | 79 | 14M | 21.2% | 22 / 26 | 13 / 12 | 9M | 1M |
| Q4 2025 | 71 | 11M | 17.0% | 19 / 17 | 15 / 13 | 4M | 1M |
| Q3 2025 | 68 | 9M | 13.4% | 27 / 21 | 4 / 9 | 5M | 0M |
| Q2 2025 | 50 | 4M | 6.5% | 14 / 15 | 8 / 8 | 2M | 0M |
| Q1 2025 | 44 | 2M | 3.2% | 11 / 19 | 1 / 5 | 1M | 0M |
| Q4 2024 | 39 | 1M | 1.6% | 14 / 6 | 7 / 1 | 0M | 0M |
| Q3 2024 | 26 | 1M | 1.6% | 3 / 5 | 5 / 12 | 0M | 0M |
| Q2 2024 | 36 | 1M | 1.6% | 8 / 4 | 9 / 5 | 0M | 0M |
| Q1 2024 | 33 | 1M | 2.2% | 5 / 8 | 5 / 8 | 0M | 1M |
| Q4 2023 | 36 | 2M | 2.3% | 9 / 8 | 8 / 4 | 1M | 0M |
| Q3 2023 | 31 | 1M | 1.5% | 6 / 4 | 6 / 3 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
24 funds held MBOT in Q2 2026, 72% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of MBOT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2,109,889 | 3.14% | $4.11M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 739,816 | 1.10% | $1.44M | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 354,098 | 0.53% | $718.82K | 0.00% | May 31, 2026 |
| AlphaCentric Robotics and Automation Fund | 250,000 | 0.37% | $487.50K | 1.83% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 230,924 | 0.34% | $450.30K | 0.03% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 116,869 | 0.17% | $237.24K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 101,606 | 0.15% | $206.26K | 0.00% | May 31, 2026 |
| Avantis U.S. Small Cap Equity ETF | 93,314 | 0.14% | $189.43K | 0.01% | May 31, 2026 |
| Schwab Total Stock Market Index Fund | 50,000 | 0.07% | $86.00K | 0.00% | Jul 31, 2026 |
| Ultra-Small Company Fund | 44,300 | 0.07% | $86.39K | 0.09% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 36,401 | 0.05% | $73.89K | 0.00% | May 31, 2026 |
| Fidelity ZERO Total Market Index Fund | 34,564 | 0.05% | $59.45K | 0.00% | Jul 31, 2026 |
| Vanguard Balanced Index Fund | 32,414 | 0.05% | $63.21K | 0.00% | Jun 30, 2026 |
| Invesco NASDAQ Future Gen 200 ETF | 31,884 | 0.05% | $64.72K | 0.34% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 24,691 | 0.04% | $48.15K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Harel Gadot | Chairman, President and CEO, Director | 136,847 | 0.20% | Feb 20, 2026 |
| Simon Sharon | General Manager, CTO | – | – | Feb 20, 2026 |
| Rachel Vaknin | Chief Financial Officer | – | – | Feb 20, 2026 |
| Juan Diaz-Cartelle | Chief Medical Officer | – | – | Feb 20, 2026 |
| Tal Baruch Wenderow | Director | – | – | Apr 3, 2026 |
| Scott R. Burell | Director | – | – | Apr 3, 2026 |
| David James Wilson | Director | – | – | Apr 3, 2026 |
| Martin J. Madden | Director | – | – | Apr 3, 2026 |
| Prattipati Laxminarain | Director | – | – | Apr 3, 2026 |
| Aileen Ptucha Stockburger | Director | – | – | Apr 3, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Yoseph Bornstein Director | Oct 19, 2020 | Sale(10b5-1 plan) | −4,881 | $7.94 | $38.76K | 242,028 |
| Yoseph Bornstein Director | Oct 12, 2020 | Sale(10b5-1 plan) | −20,000 | $7.84 | $156.80K | 246,909 |
| Yoseph Bornstein Director | Oct 5, 2020 | Sale(10b5-1 plan) | −20,000 | $7.84 | $156.80K | 246,909 |
| Yoseph Bornstein Director | Oct 5, 2020 | Sale(10b5-1 plan) | −14,881 | $7.74 | $115.18K | 272,028 |
| Yoseph Bornstein Director | Oct 5, 2020 | Sale(10b5-1 plan) | −5,119 | $7.74 | $39.62K | 266,909 |
| Yoseph Bornstein Director | Aug 17, 2020 | Sale(10b5-1 plan) | −119 | $11.91 | $1.42K | 286,909 |
| Yoseph Bornstein Director | Aug 17, 2020 | Sale(10b5-1 plan) | −15,000 | $10.18 | $152.70K | 287,028 |
| Harel Gadot Chairman, President and CEO, Director | Dec 23, 2019 | Sale(10b5-1 plan) | −40,000 | $10.00 | $400.00K | 136,847 |
| Joseph Mona 10% owner | Jan 14, 2019 | Sale | −281,773 | $8.16 | $2.30M | 0 |
| Joseph Mona 10% owner | Jan 14, 2019 | Buy | +1,773 | $6.43 | $11.40K | 0 |
| Joseph Mona 10% owner | Jan 14, 2019 | Sale | +281,773 | $8.16 | $2.30M | 0 |
| Joseph Mona 10% owner | Jan 9, 2019 | Sale | −1,280 | $2.27 | $2.91K | 0 |
| Joseph Mona 10% owner | Jan 9, 2019 | Buy | +14,280 | $2.19 | $31.27K | 0 |
| Joseph Mona 10% owner | Jan 9, 2019 | Sale | +2,269 | $2.70 | $6.13K | 0 |
| Joseph Mona 10% owner | Jan 9, 2019 | Buy | +14,280 | $2.19 | $31.27K | 0 |
| Joseph Mona 10% owner | Jan 8, 2019 | Sale | −2,269 | $2.70 | $6.13K | 0 |
| Joseph Mona 10% owner | Jan 8, 2019 | Sale | +2,269 | $2.70 | $6.13K | 0 |
| Joseph Mona 10% owner | Nov 26, 2018 | Buy | +37,986 | $1.95 | $74.07K | 348,971 |
| Joseph Mona 10% owner | Nov 21, 2018 | Sale | +6,309 | $2.96 | $18.67K | 348,971 |
| Joseph Mona 10% owner | Nov 21, 2018 | Buy | +24,873 | $2.21 | $54.97K | 348,971 |
| Joseph Mona 10% owner | Nov 19, 2018 | Buy | +2,400 | $2.99 | $7.18K | 348,971 |
| Yoseph Bornstein Director, 10% owner | Jan 9, 2018 | Sale(10b5-1 plan) | −35,000 | $1.06 | $37.10K | 4,530,409 |
| Yoseph Bornstein Director, 10% owner | Jan 3, 2018 | Sale(10b5-1 plan) | −2,868 | $1.01 | $2.90K | 4,565,409 |
| Yoseph Bornstein Director, 10% owner | Jan 2, 2018 | Sale(10b5-1 plan) | −42,132 | $1.01 | $42.55K | 4,568,277 |
| Yoseph Bornstein Director, 10% owner | Dec 27, 2017 | Sale(10b5-1 plan) | −14,257 | $1.02 | $14.54K | 4,610,409 |
| Yoseph Bornstein Director, 10% owner | Dec 26, 2017 | Sale(10b5-1 plan) | −30,743 | $1.02 | $31.36K | 4,624,666 |
| Yoseph Bornstein Director, 10% owner | Dec 20, 2017 | Sale(10b5-1 plan) | −12,933 | $1.03 | $13.32K | 4,655,409 |
| Yoseph Bornstein Director, 10% owner | Dec 19, 2017 | Sale(10b5-1 plan) | −32,067 | $1.03 | $33.03K | 4,655,409 |
| Yoseph Bornstein Director, 10% owner | Dec 13, 2017 | Sale(10b5-1 plan) | −841 | $1.02 | $858 | 4,700,409 |
| Yoseph Bornstein Director, 10% owner | Dec 12, 2017 | Sale(10b5-1 plan) | −44,159 | $1.04 | $45.93K | 4,701,250 |
| Yoseph Bornstein Director, 10% owner | Dec 6, 2017 | Sale(10b5-1 plan) | −15,375 | $1.05 | $16.14K | 4,745,409 |
| Yoseph Bornstein Director, 10% owner | Dec 5, 2017 | Sale(10b5-1 plan) | −29,625 | $1.08 | $32.00K | 4,760,784 |
| Yoav Zvi Waizer Director | Dec 5, 2017 | Sale | −10,000 | $1.08 | $10.80K | 0 |
| Yoav Zvi Waizer Director | Dec 4, 2017 | Buy | +10,000 | $1.10 | $11.00K | 10,000 |
| Yoseph Bornstein Director, 10% owner | Nov 28, 2017 | Sale(10b5-1 plan) | −45,000 | $1.07 | $48.15K | 4,790,409 |
| Yoseph Bornstein Director, 10% owner | Nov 21, 2017 | Sale(10b5-1 plan) | −45,000 | $1.21 | $54.45K | 4,835,409 |
| Yoseph Bornstein Director, 10% owner | Oct 24, 2017 | Sale(10b5-1 plan) | −25,000 | $1.13 | $28.25K | 4,880,399 |
| Yoseph Bornstein Director, 10% owner | Oct 24, 2017 | Sale(10b5-1 plan) | −25,000 | $1.14 | $28.50K | 4,880,399 |
| Yoseph Bornstein Director, 10% owner | Oct 17, 2017 | Sale(10b5-1 plan) | −25,000 | $1.16 | $29.00K | 4,930,399 |
| Yoseph Bornstein Director, 10% owner | Oct 17, 2017 | Sale(10b5-1 plan) | −25,000 | $1.17 | $29.25K | 4,930,399 |
| Yoseph Bornstein Director, 10% owner | Oct 10, 2017 | Sale(10b5-1 plan) | −25,000 | $1.37 | $34.25K | 5,020,409 |
| Yoseph Bornstein Director, 10% owner | Oct 10, 2017 | Sale(10b5-1 plan) | −25,000 | $1.39 | $34.75K | 5,020,409 |
| Moshe Shoham Director | Oct 9, 2017 | Sale(10b5-1 plan) | −16,600 | $1.50 | $24.90K | 1,558,390 |
| Moshe Shoham Director | Oct 5, 2017 | Sale(10b5-1 plan) | −17,100 | $1.50 | $25.65K | 1,558,390 |
| Yoseph Bornstein Director, 10% owner | Oct 5, 2017 | Sale(10b5-1 plan) | −22,000 | $1.49 | $32.78K | 5,070,409 |
| Yoseph Bornstein Director, 10% owner | Oct 4, 2017 | Sale(10b5-1 plan) | −3,000 | $1.48 | $4.44K | 5,092,409 |
| Yoseph Bornstein Director, 10% owner | Oct 3, 2017 | Sale(10b5-1 plan) | −25,000 | $1.19 | $29.75K | 5,092,409 |
| Yoseph Bornstein Director, 10% owner | Oct 3, 2017 | Sale(10b5-1 plan) | −25,000 | $1.17 | $29.25K | 5,092,409 |
| Yoseph Bornstein Director, 10% owner | Sep 26, 2017 | Sale(10b5-1 plan) | −25,000 | $1.23 | $30.75K | 5,145,409 |
| Yoseph Bornstein Director, 10% owner | Sep 26, 2017 | Sale(10b5-1 plan) | −25,000 | $1.25 | $31.25K | 5,145,409 |
| Yoseph Bornstein Director, 10% owner | Sep 19, 2017 | Sale | −25,000 | $1.18 | $29.50K | 5,195,409 |
| Yoseph Bornstein Director, 10% owner | Sep 19, 2017 | Sale | −25,000 | $1.19 | $29.75K | 5,220,409 |
| Moshe Shoham Director | Sep 15, 2017 | Sale(10b5-1 plan) | −40,500 | $1.26 | $51.03K | 1,592,090 |
| Moshe Shoham Director | Sep 15, 2017 | Sale(10b5-1 plan) | −28,657 | $1.26 | $36.11K | 1,592,090 |
| Moshe Shoham Director | Sep 15, 2017 | Sale(10b5-1 plan) | −20,276 | $1.27 | $25.75K | 1,592,090 |
| Moshe Shoham Director | Sep 15, 2017 | Sale(10b5-1 plan) | −400 | $1.27 | $508 | 1,592,090 |
| Moshe Shoham Director | Sep 15, 2017 | Sale(10b5-1 plan) | −27,384 | $1.27 | $34.78K | 1,592,090 |
| Moshe Shoham Director | Sep 15, 2017 | Sale(10b5-1 plan) | −1,200 | $1.28 | $1.54K | 1,592,090 |
| Moshe Shoham Director | Sep 15, 2017 | Sale(10b5-1 plan) | −14,400 | $1.28 | $18.43K | 1,592,090 |
| Moshe Shoham Director | Sep 15, 2017 | Sale(10b5-1 plan) | −11,083 | $1.29 | $14.30K | 1,592,090 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Microbot Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 78,840 shares on Sep 11, 2026 over the last 90 days.
See a number that looks wrong?